These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 7672048)

  • 1. Blood-borne virus infections among Australian injecting drug users: implications for spread of HIV.
    Crofts N; Hopper JL; Milner R; Breschkin AM; Bowden DS; Locarnini SA
    Eur J Epidemiol; 1994 Dec; 10(6):687-94. PubMed ID: 7672048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users.
    Devi KhS; Singh NB; Singh HL; Singh YM
    J Indian Med Assoc; 2009 Mar; 107(3):144, 146-7. PubMed ID: 19810379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus infection among a cohort of Victorian injecting drug users.
    Crofts N; Hopper JL; Bowden DS; Breschkin AM; Milner R; Locarnini SA
    Med J Aust; 1993 Aug; 159(4):237-41. PubMed ID: 7692222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017).
    Scheibe A; Young K; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Puren A; Hausler H
    BMC Infect Dis; 2020 Sep; 20(1):655. PubMed ID: 32894072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
    Rahimi-Movaghar A; Razaghi EM; Sahimi-Izadian E; Amin-Esmaeili M
    Int J Infect Dis; 2010 Jan; 14(1):e28-33. PubMed ID: 19464218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
    Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
    Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh.
    Shirin T; Ahmed T; Iqbal A; Islam M; Islam MN
    J Health Popul Nutr; 2000 Dec; 18(3):145-50. PubMed ID: 11262767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of HBV, HDV and HCV hepatitis markers in HIV-positive patients.
    Francisci D; Baldelli F; Papili R; Stagni G; Pauluzzi S
    Eur J Epidemiol; 1995 Apr; 11(2):123-6. PubMed ID: 7672063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 2004 Australian prison entrants' blood-borne virus and risk behaviour survey.
    Butler T; Boonwaat L; Hailstone S; Falconer T; Lems P; Ginley T; Read V; Smith N; Levy M; Dore G; Kaldor J
    Aust N Z J Public Health; 2007 Feb; 31(1):44-50. PubMed ID: 17333608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.
    Babudieri S; Longo B; Sarmati L; Starnini G; Dori L; Suligoi B; Carbonara S; Monarca R; Quercia G; Florenzano G; Novati S; Sardu A; Iovinella V; Casti A; Romano A; Uccella I; Maida I; Brunetti B; Mura MS; Andreoni M; Rezza G
    J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on the blood-borne virus co-infection and T lymphocyte subset among intravenous drug users.
    Li JR; Gong RY; Tian KL; Wang J; Wang YX; Huang HJ
    World J Gastroenterol; 2007 Apr; 13(16):2357-62. PubMed ID: 17511038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HIV seropositivity was related to HBsAg seropositivity among injecting drug users in Taiwan.
    Hsieh MH; Hsieh MY; Huang CF; Yeh ML; Wang SC; Yang JF; Chang K; Lin WR; Lin CY; Chen TC; Huang JF; Dai CY; Tsai JJ; Chuang WL; Yu ML
    Kaohsiung J Med Sci; 2016 Feb; 32(2):96-102. PubMed ID: 26944329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence and risk behaviours associated with the transmission of blood-borne viruses among ethnic-Vietnamese injecting drug users.
    Hellard ME; Nguyen OK; Guy RJ; Jardine D; Mijch A; Higgs PG
    Aust N Z J Public Health; 2006 Dec; 30(6):519-25. PubMed ID: 17209266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks.
    Panda S; Chatterjee A; Bhattacharjee S; Ray B; Saha MK; Bhattacharya SK
    Int J STD AIDS; 1998 Apr; 9(4):214-8. PubMed ID: 9598748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus infection: prevalence, predictor variables and prevention opportunities among drug users in Italy.
    Quaglio GL; Lugoboni F; Pajusco B; Sarti M; Talamini G; Mezzelani P; Des Jarlais DC;
    J Viral Hepat; 2003 Sep; 10(5):394-400. PubMed ID: 12969192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.
    Miller ER; Hellard ME; Bowden S; Bharadwaj M; Aitken CK
    J Infect; 2009 May; 58(5):375-82. PubMed ID: 19328555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
    Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
    Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infections among people who inject drugs in Kuwait: A cross-sectional study.
    Altawalah H; Essa S; Ezzikouri S; Al-Nakib W
    Sci Rep; 2019 Apr; 9(1):6292. PubMed ID: 31000775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.